Daniel L. Goodwin’s Gilead Sciences GILD Stock Holding History

Daniel L. Goodwin’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,550	Closed	-$358K	–	91
2019 Q4	$358K	Sell	5,550 -12,400	-69%	-$808K	0.16%	64
2019 Q3	$1.14M	Hold	17,950	–	–	0.51%	28
2019 Q2	$1.22M	Hold	17,950	–	–	0.55%	25
2019 Q1	$1.17M	Hold	17,950	–	–	0.54%	27
2018 Q4	$1.12M	Hold	17,950	–	–	0.59%	22
2018 Q3	$1.39M	Hold	17,950	–	–	0.66%	20
2018 Q2	$1.27M	Hold	17,950	–	–	0.59%	20
2018 Q1	$1.35M	Sell	17,950 -200	-1%	-$15.9K	0.66%	17
2017 Q4	$1.3M	Sell	18,150 -100	-0.5%	-$7.59K	0.57%	19
2017 Q3	$1.48M	Sell	18,250 -500	-3%	-$38.2K	0.66%	18
2017 Q2	$1.33M	Sell	18,750 -50	-0.3%	-$3.33K	0.6%	21
2017 Q1	$1.28M	Buy	18,800 +3,800	+25%	+$267K	0.53%	21
2016 Q4	$1.07M	Buy	15,000 +5,000	+50%	+$372K	0.43%	27
2016 Q3	$791K	Buy	+10,000	New	+$812K	0.28%	38

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Daniel L. Goodwin's GILD Position: Q1 2020 in Review

Daniel L. Goodwin sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 5,550 shares — an estimated $358K sold.

Daniel L. Goodwin first reported a position in GILD in Q3 2016 and held it in 14 quarters. The position peaked at $1.48M in Q3 2017. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

Daniel L. Goodwin reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
Daniel L. Goodwin sold 5,550 Gilead Sciences shares in Q1 2020, an estimated $358K.
Daniel L. Goodwin first reported a position in Gilead Sciences in Q3 2016 and held it in 14 quarters.
Daniel L. Goodwin's Gilead Sciences position peaked at $1.48M in Q3 2017.
1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Daniel L. Goodwin's 13F filing for Q1 2020, filed 17 Apr 2020.